Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
49,572,574
-
Share change
-
-5,786,468
-
Total reported value
-
$25,279,551
-
Put/Call ratio
-
9.6%
-
Price per share
-
$0.51
-
Number of holders
-
102
-
Value change
-
-$2,592,583
-
Number of buys
-
30
-
Number of sells
-
59
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q4 2023
As of 31 Dec 2023,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
49,572,574 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
102
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.